Home » Topics » Disease categories and therapies » Neurology/Psychiatric

Neurology/Psychiatric
RSS

Synapton phase III trials concluded

Aug. 30, 1996

No Comments

Prednisone suppresses acute phase in AD patients

Aug. 30, 1996

No Comments

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

No Comments

Botulinum toxin effective in reducing upper limb spasticity

Aug. 30, 1996

No Comments

Roche files for approval of Tasmar

Aug. 30, 1996

No Comments

Tegretol-XR launched in U.S.

Aug. 30, 1996

No Comments

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

No Comments

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

No Comments

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

No Comments

Famotidine tested in schizophrenic patients

Aug. 30, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/Psychiatric
RSS

Synapton phase III trials concluded

Prednisone suppresses acute phase in AD patients

Botulinum toxin effective in treating writer's cramp

Botulinum toxin effective in reducing upper limb spasticity

Roche files for approval of Tasmar

Tegretol-XR launched in U.S.

CGP-25454 tested in healthy volunteers

Correlation established between serum PLA2 activity and schizophrenia symptoms

Potential antipsychotic described by Parke-Davis

Famotidine tested in schizophrenic patients

Today's news in brief

Today's news in brief

Dato data lack means upside for Gilead; Padcev 'must-win' does win

Study identifies cause of death for Alzheimer’s neurons

Apple scores win over Masimo for patents for physiological detectors, but ITC decision awaits

Neurology/Psychiatric RSS

Neurology/Psychiatric
RSS